ABSTRACT
D
evelopmental venous anomalies (DVAs) are frequently identified on routine MR imaging of the brain with contrast. DVAs are typically considered normal variants of venous development and usually have no associated imaging findings.
However, a subset of DVAs has been associated with findings such as cavernous malformations (CMs), [1] [2] [3] thrombosis with subsequent venous infarction, [4] [5] [6] [7] [8] lobar atrophy, 9 T2 and FLAIR signal-intensity abnormalities, 9, 10 and SWI hypointensities. 11 Signal abnormalities can occur in the drainage territory of DVAs and may produce diagnostic uncertainty with regard to the significance and relationship to presenting symptoms. Signal abnormalities on MR imaging have been described in 12.5% 10 to 28.3% 9 of DVAs in adults, with an increasing prevalence with older age. While well described in adults, this relationship has not been investigated in children, to our knowledge. The MR imaging appearance of the brain in children is quite different from that in adults during myelination, and the effect of DVAs on regional brain maturation has not been studied.
The most commonly proposed etiologies for parenchymal abnormalities associated with DVAs are chronic venous hypertension/insufficiency leading to ischemia or microhemorrhage. [9] [10] [11] [12] Although the effect of brain maturation is unknown, on the basis of these pathophysiologic mechanisms, we hypothesized that parenchymal abnormalities would be less common in children compared with adults. This study was performed to test this hypothesis and to investigate clinical factors and DVA characteristics associated with parenchymal signal abnormalities in children and young adults.
MATERIALS AND METHODS

Cohort Identification
This retrospective study was approved by our institutional review board. The study was performed at a tertiary care children's hospital. A cutoff age of 35 years was chosen to ensure some age overlap with a similar study performed in adults. 10 Using a radiology data base search engine (Softek Illuminate; Softek Solutions, Prairie Village, Kansas), we searched brain MR imaging with contrast reports for the term "developmental venous anomaly" from November 2008 to November 2012. This search resulted in the identification of 285 consecutive patients with developmental venous anomalies identified on brain MR imaging with contrast. The examinations were reviewed by a neuroradiologist (J.L.L.) and pediatric neuroradiology fellow (L.L.L.). Criteria for inclusion in the study were the following: 1) subjects were younger than 35 years in age, 2) subjects had undergone MR imaging of the brain with contrast, and 3) the term "developmental venous anomaly" was used by the interpreting radiologist in the subject's final diagnostic radiology report. Exclusion criteria based on imaging included the following: incomplete/nondiagnostic examinations (defined as those examinations that did not include FLAIR or T2-weighted imaging or examinations limited by motion or other artifacts, 5 subjects), examinations in which the presence of a DVA was questionable on imaging review (23 subjects), and examinations in which the DVA was too small to characterize its morphology (35 subjects). Also excluded were subjects with underlying diagnoses that alone could explain the presence of parenchymal signal abnormalities, including tuberous sclerosis, neurofibromatosis type 1, intracranial vascular malformations (eg, Sturge-Weber Syndrome, dural arteriovenous fistulas, and so forth), and subjects who had undergone surgery involving brain parenchyma in the drainage territory of the DVA (50 subjects).
Imaging
One hundred thirty-six DVAs were scanned at 1.5T, and 57 DVAs were scanned at 3T. Typical 3T protocol included the following: a 3D volumetric T1-weighted gradient-echo sequence (TR, 10 ms; TE, 4.6 ms), an axial T2-weighted sequence (TR, 3000 ms; TE, 100 ms), and an axial T2-weighted FLAIR sequence (TR, 11,000 ms; TE, 125 ms; TI, 2800 ms). The 1.5T protocol included the following: a sagittal T1-weighted FLAIR sequence (TR, 2200 ms; TE, 26 ms), an axial T2-weighted sequence (TR, 5000 ms; TE, 85 ms), and a T2 FLAIR sequence (TR, 10,000 ms; TE, 120 ms; TI, 2200 ms). Section thickness was 3-5 mm with a 0-to 1-mm intervening gap. Postcontrast imaging included a 3D volumetric T1 gradientecho sequence for 3T examinations and a T1-weighted FLAIR sequence in 3 planes for 1.5T examinations. Gadolinium was administered at a dose of 0.2 mmol/kg intravenously.
Image Analysis
The examinations were reviewed in detail by 2 experienced radiologists. The first radiologist (J.L.L.) has 20 years of experience in interpreting MR imaging examinations and holds a Certificate of Added Qualification in neuroradiology. The second radiologist (L.L.L.) has 6 years of experience in interpreting MR imaging examinations and is currently a clinical fellow in pediatric neuroradiology.
DVA location was divided into 3 groups: 1) lobar, 2) basal ganglia/thalamus, and 3) brain stem/cerebellum. DVA morphology was described by using a previously published system devised by Lee et al. 13 The DVAs were classified by depth as juxtacortical, subcortical, or periventricular. "Juxtacortical" depth was defined as within the gray matter or at the gray-white junction. "Subcortical" depth was defined as below the juxtacortical region but not adjacent to the ventricular wall. "Periventricular" depth was defined as adjacent to the lateral, third, or fourth ventricle or within the center of the structure, such as the pons. The drainage direction of the terminal or draining vein to which the venous radicles join was classified as either a deep (toward the ventricle) draining vein, superficial (toward the brain surface) draining vein, or both deep and superficial draining veins. Images were specifically reviewed for the following: parenchymal atrophy, increased signal intensity on both FLAIR and T2-weighted images, and cavernous malformations within the drainage territory of the DVA. "Cavernous malformations" were defined as focal lesions with T2 hypointense borders and associated exaggerated signal hypointensity on gradient recalled-echo or SWI sequences. Signal-intensity abnormalities associated with the DVA were defined as increased extravascular signal intensity on both FLAIR and T2-weighted images within the drainage territory of the DVA. 9, 10 The drainage territory was defined as the brain parenchyma directly adjacent to the visualized radicles of the DVA. Special care was taken to exclude increased signal intensity often seen within the venous radicles or draining vein, as described previously. 10 In infants and young children, signal abnormality was defined as signal intensity qualitatively greater than that of surrounding white matter and white matter in the corresponding gyrus of the contralateral cerebral hemisphere. The prevalence of signal-intensity abnormalities within the DVA drainage territory was correlated with the presence or absence of CM and parenchymal atrophy, as well as DVA location, depth of the draining vein, direction of the draining vein, age, and sex. For those patients with associated signal abnormality, follow-up duration and number of follow-up examinations were tabulated. Follow-up examinations were reviewed to determine whether the extent or character of parenchymal signal abnormality changed with time.
Clinical and Imaging Findings Correlation
Clinical indications and dominant imaging findings (other than the presence of a DVA) were identified from the radiology report (or electronic medical record, when necessary) for all DVAs with and without associated signal abnormality. They were then correlated with the presence or absence of DVA-associated signal intensity in the DVA drainage territory. . Values for the 2-sample t test are expressed as mean Ϯ SD (95% CI) unless stated otherwise. OR for age was calculated as the likelihood of signal abnormality with each additional year. OR for sex was calculated as the likelihood of signal abnormality if the subject was female. ORs for focal atrophy and CM were calculated as the likelihood of signal abnormality in the presence of either associated abnormality. ORs for location, depth, and direction of the draining vein were calculated as the likelihood of signal abnormality compared with the first DVA morphologic descriptor (ie, lobar, periventricular, superficial), which was given an OR of 1.0. Multivariate logistic regression models (PЉ) were used to evaluate the independent effects of age, sex, CM, parenchymal atrophy, location, depth, and direction of draining vein on signal change. Model selection under a stepwise criterion was performed to avoid multicollinearity. P Ͻ .05 was considered statistically significant. All analyses were performed by using SAS statistical software, Version 9.3 (SAS Institute, Cary, North Carolina.)
Statistical Analysis
RESULTS
Of the 285 subjects initially identified in our data base search, 172 met the inclusion criteria. The mean age of the cohort was 10.8 years (14 months to 34 years) with an SD of 6.6 years and a 95% CI of 9.9 -11.8 years. The cohort consisted of 91 males and 81 females. In these 172 subjects, 193 DVAs were identified. Thirteen patients had Ͼ1 DVA (11 subjects had 2 DVAs identified and 2 subjects had Ͼ2 DVAs identified There was a trend toward lobar location being associated with signal abnormality, but this did not reach statistical significance (PЈ ϭ 0.26, PЉ ϭ 0.589). The depth of the DVA was found to be associated with signal abnormality by using 2 analysis, but it did not reach statistical significance by using a multivariate logistic regression analysis. Specifically, periventricular depth was more likely to be associated with signal abnormality than juxtacortical or subcortical depth. Eight of 27 (29.6%) periventricular DVAs had associated signal abnormalities versus 8/96 (8.3%) juxtacortical and 10/70 (14.3%) subcortical DVAs (PЈ ϭ .016, PЉ ϭ .909). The direction of venous drainage was independently associated with signal abnormality. Specifically, deep or bidirectional venous drainage was more likely to be associated with signal abnormality than superficial venous drainage. Fourteen of 66 (21.2%) deep and 3/6 (50%) bidirectional draining DVAs had associated signal abnormalities versus 9/121 (7.4%) superficial draining DVAs (PЈ ϭ .001, PЉ ϭ .047). A lower subject age was associated with signal abnormality. Specifically, the median age of those subjects with signal abnormality was 7.3 Ϯ 5.5 years (95% CI, 5.1-9.5) compared with 11.4 Ϯ 6.6 years (95% CI, 10.4 -12.4) for those subjects without signal abnormalities (PЈ ϭ .003, PЉ ϭ .001). When subsets of age groups were further investigated, the prevalence of signal abnormalities was 5/19 (26%) in subjects 12-36 months, 12/68 (17.6%) in subjects 3-10 years, 4/75 (5.6%) in subjects 11-20 years, and 1/11 (9.1%) in subjects older than 20 years of age (Fig 4) . An example of signal abnormality in the very young age group (12-36 months) is given in Fig 5. There was a trend toward more males with signal abnormalities than females, but this was not statistically significant (PЈ ϭ .538, PЉ ϭ .918). We found no association between clinical indication and signal abnormalities. Secondary imaging findings of CMs and atrophy remote from the DVA were associated with signal abnormalities (On-line Table 1 ). Secondary imaging findings of remote intracranial mass were associated with the absence of signal abnormality (On-line Table 2 ).
Twenty-one of 26 (80.1%) DVAs with associated signal abnormality had follow-up examinations with a median follow-up of 26 months (1-42 months) . The median number of follow-up MR imaging examinations for these 21 DVAs was 2 (1-7 examinations). There was no change in the extent or character of signal abnormalities on follow-up in 19 of 21 DVAs with associated signal abnormality alone. Two DVAs with signal abnormality alone showed a subtle decrease in signal abnormality on follow-up examinations. These patients were 2 years and 17 months of age at the time of initial study with a follow-up of 3 and 4 years, respectively (Fig 6) . Two of ; PЉ, multivariate logistic regression; brackets, 95% confidence interval for age. a OR for age is expressed as the likelihood of signal abnormality with each additional year. OR for sex is expressed as the likelihood of signal abnormality for a female subject. ORs for focal atrophy and CM are expressed as the likelihood of signal abnormality in the presence of either associated abnormality. ORs for location, depth, and direction of draining vein are expressed as the likelihood of signal abnormality compared with the first DVA morphologic descriptor (eg, lobar, periventricular, superficial), defined as a baseline OR of 1.0. b % is the percentage of DVAs with a certain characteristic or associated finding divided by the total number of DVAs with signal abnormality. c % is the percentage of DVAs with a certain characteristic or associated finding divided by the total number of DVAs without signal abnormality. d % is the percentage of DVAs with a certain characteristic or associated finding divided by the total number of DVAs. the 5 DVAs with signal abnormality and associated CMs showed a decrease in signal hyperintensity on follow-up examinations.
DISCUSSION
The major finding of this study is that in children and young adults, signal-intensity abnormalities detectable by MR imaging were identified in 11.6% of consecutively identified DVAs. This is similar to the prevalence identified in prior investigations of adult patients. 10 Although not proved, our results suggest that these signal abnormalities occur with a higher prevalence in younger patients and may decrease with brain maturation. To our knowledge, this is a novel finding because change in signal with time has not been identified in any of the similar studies performed in adults. [9] [10] [11] Additional parenchymal abnormalities such as CMs and parenchymal atrophy were strongly associated with signal abnormalities. Finally, we identified deep venous drainage as the only morphologic characteristic of DVAs that is independently predictive of associated signal abnormality.
The etiology of parenchymal signal abnormalities associated with DVAs in adults and children is incompletely understood. Prior investigators have suggested that abnormal FLAIR signal intensity may represent edema or gliosis secondary to chronic venous insufficiency/ hypertension related to anomalous venous drainage.
9,10 Altered hemodynamics in the drainage territory of DVAs has been established with case reports that described increased perfusion parameters in "atypical" DVAs. 14, 15 More recently, a larger study of DVAs found increased relative CBV, relative CBF, and MTT in most DVA studies. 12 Additionally, they found that those DVAs with associated CMs had higher MTT values than those DVAs without CMs, suggesting that hemodynamic factors may influence parenchymal manifestations of DVAs. A similar study of perfusion parameters in the setting of white matter signal abnormalities would be informative. Perfusion was performed in too few of our cases to evaluate its possible contribution to signal abnormalities. Other studies have suggested that stenosis of the draining vein may cause venous hypertension/insufficiency. 16, 17 A recent investigation of morphologic factors associated with CMs and DVAs found tortuosity of the medullary veins and angulation of the draining vein to be associated with the presence of a CM in the DVA territory. 18 This finding also supports the hypothesis that hemodynamic variables may impact the presence of parenchymal abnormalities. Given the small size of most DVAs in our study, resolution was not adequate to assess draining vein stenosis and medullary vein tortuosity. Based on these prior investigations of parenchymal abnormalities associated with DVAs, our hypothesis was that the prevalence of white matter signal abnormalities would be less common in children than in adults. Contrary to our hypothesis, we found a nearly equal prevalence of brain parenchymal signal abnormalities in children and young adults (median age, 10 years) (11.6%) compared with older adults (median age, 47 years) (12.5%). 10 Most interesting, when we performed a subset analysis by age group, we identified an unexpected inverse relationship between subject age and signal abnormality, with the highest prevalence being found in the youngest subjects and the lowest prevalence in teenagers. When we compared our findings with those of Santucci et al, 10 which found a higher prevalence of signal abnormalities in older patients, a bimodal age distribution of signal abnormalities is suggested. The highest prevalence of signal abnormalities occurs in the very young, steadily decreases to a nadir in the teenage and early adult years, and then increases with age. One possible explanation for this finding is delayed myelination in the drainage territory of the DVA in young children. Perhaps alterations in the venous pressure within the DVA cause delayed egress of inter- stitial water as myelination progresses in infancy and early childhood, leading to relatively increased signal intensity in the brain parenchyma drained by the DVA. 19 If the higher prevalence of signal abnormalities in a younger population is to be explained by delayed myelination, we would expect some percentage of these signal abnormalities to decrease or resolve with time with progressive myelination. In fact, this was our observation, because 2 of the 21 DVAs with signal abnormality alone did demonstrate subtle decreased signal abnormality on follow-up examinations. On the basis of our study and the existing adult literature, it is interesting to speculate that myelination changes may be primarily responsible for signal abnormalities in the DVA drainage territory in infants and young children, resolving or becoming less apparent in older children and adolescents. With aging, gliosis may become a more dominant process, becoming nonreversible on imaging evaluation. Additional investigations with larger populations of young children, expanded mixed-age populations, and more subjects with long-term follow-up will be needed to confirm these age associations.
As we investigated the possible association of DVA morphology and location with the presence of signal abnormality, we identified deep venous drainage as the only independently predictive variable. The physiologic basis for this association is uncertain, but perhaps cerebral deep venous drainage has less venous flow capacity and may be more likely to cause venous insufficiency/hypertension. Deep venous drainage has been identified as a significant predictor of hemorrhage in arteriovenous malformations. [20] [21] [22] We found no significant association between the location of the DVA and signal abnormality. This finding is supported by a similar study in adults, which found no association with DVA location. 10 The DVA depth was associated with signal abnormality when using univariate analysis, but not when using a multivariate analysis, suggesting that the influence of depth on signal is related, in some fashion, to the direction of drainage.
In the course of our investigation of white matter signal abnormalities, we were interested in identifying the prevalence of other well-documented parenchymal abnormalities associated with DVAs, namely CMs 1-3 and parenchymal atrophy. 9 The prevalence of CMs (6.2%) in our study population is similar to that of 2 previously reported studies investigating the association of DVAs and CMs in adults, which found CMs in 3.4% 10 and 13.3% of DVAs. 9 This outcome was contrary to our expectations because many have suggested that the development of CMs in the DVA drainage territory is a dynamic process that evolves with time, beginning with small microhemorrhages within the drainage territory of DVAs. [23] [24] [25] [26] [27] Under such a scenario, one would expect the prevalence of CMs associated with DVAs to increase with time and be more common in adults than in children. We also found that those DVAs with CMs were more likely to have associated signal abnormality. Despite the small number of cavernous malformations, this association reached statistical significance. The association between signal abnormality and CMs is problematic because the etiology of the signal abnormality may not be confidently attributed to the presence of the DVA alone. One could argue that the signal abnormality is secondary to hemorrhage of the CM; however, this association between signal abnormality and cavernous malformations is supported by a recent investigation of DVAs in adults by using susceptibility-weighted imaging to identify the prevalence of hypointense foci on SWI within the drainage territory of DVAs. 11 The study found that white matter hyperintense lesions were more frequently observed in patients with hypointense SWI foci versus those without hypointense SWI foci. Additionally, the study found a 62% prevalence of SWI hypointense foci in the study population, which is much higher than that in our study. This discrepancy may, in part, be explained by the relatively small number of examinations that included SWI in our study. Alternatively, SWI hypointense foci may be less com- monly encountered in the pediatric population. A dedicated examination of hypointense foci in children by using SWI is warranted. In regard to parenchymal atrophy and associated signal abnormalities, we found a low prevalence of parenchymal atrophy (4.1%), significantly less than that in a study of adults (29.7%). 9 This may be related to the development of localized atrophy with increasing age but could also be related to selection bias used in some prior investigations (ie, potentially selecting only larger DVAs for evaluation). Atrophy was more commonly encountered in those DVAs with associated signal abnormality, suggesting that these 2 parenchymal abnormalities may share common etiologic factors such as venous hypertension/insufficiency.
We found no association between clinical indication and signal abnormalities, suggesting that these signal abnormalities are predominantly asymptomatic or have no typical presenting symptoms associated with them. When we evaluated possible associations with secondary imaging findings and signal abnormalities, we found an association between CMs and atrophy remote from the DVA. The association of atrophy remote from the DVA is noteworthy. It may be that factors contributing to remote atrophy (eg, radiation, ischemia, systemic venous hypertension, and so forth) make the development of signal abnormality in the DVA territory more likely, especially if the altered hemodynamics within the DVA territory predispose this brain parenchyma to such injury. Finally, a peculiar association identified in our study was that DVAs without signal abnormality were associated with a secondary imaging finding of a remote intracranial mass. We have no explanation for this association, and it may represent a statistical anomaly.
Our study does have some limitations. Case selection was based initially on imaging reports. Some small DVAs may have been missed and therefore not selected for our study cohort. Clinical indications were often obtained from the study indication and may not fully represent the patient's clinical presentation. The relatively small number of subjects limits our ability to compare DVA characteristics and signal change between age subgroups. The differentiation between DVA-related parenchymal signal changes and intrinsic DVA-related signal can be problematic; however, it has been applied successfully in prior studies by our group.
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CONCLUSIONS
Signal-intensity abnormalities detectable by standard clinical MR images were identified in 13.5% of consecutively identified DVAs in children and young adults (11.6% adjusted prevalence when CMs were excluded). Signal abnormalities were more common in DVAs with associated CM and parenchymal atrophy, with deep venous drainage, and in younger subjects in our cohort. The pathophysiology of these signal-intensity abnormalities remains unclear but may represent effects of delayed myelination and/or alterations in venous flow within the DVA drainage territory. More work in this area is warranted. 
